< Back to search trials

A Randomized, Multicenter, Parallel-group, Phase III Study to Compare the Efficacy of Arfolitixorin Versus Leucovorin in Combination With 5 Fluorouracil, Oxaliplatin, and Bevacizumab in Patients With Advanced Colorectal Cancer (AGENT)

  • Clinicaltrials.gov #: NCT03750786
  • Acronym: AGENT
  • Tumor Type: Gastrointestinal
  • Tumor Subtype: Colorectal Any KRas
  • Tumor Stage: Metastatic (1st, 2nd, 3rd, or 4th line)
  • Type of Treatment: